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The biomedical utility of induced pluripotent stem
cells (iPSCs) will be diminished if most iPSC lines
harbor deleterious genetic mutations. Recent micro-
array studies have shown that human iPSCs carry
elevated levels of DNA copy number variation
compared with those in embryonic stem cells, sug-
gesting that these and other classes of genomic
structural variation (SV), including inversions, smaller
duplications and deletions, complex rearrange-
ments, and retroelement transpositions, may fre-
quently arise as a consequence of reprogramming.
Here we employ whole-genome paired-end DNA
sequencing and sensitive mapping algorithms to
identify all classes of SV in three fully pluripotent
mouse iPSC lines. Despite the improved scope and
resolution of this study, we find few spontaneous
mutations per line (one or two) and no evidence
for endogenous retroelement transposition. These
results show that genome stability can persist
throughout reprogramming, and argue that it is
possible to generate iPSCs lacking gene-disrupting
mutations using current reprogramming methods.
INTRODUCTION
The process of direct reprogramming transforms differentiated
somatic cells into induced pluripotent stem cell (iPSC) lines
that possess the capacity to generate all cell types in an
organism. Although iPSCs are functionally similar to embryonic
stem cells (ESCs), several aspects of iPSC production suggest
that these cellsmay harbor increased numbers ofmutations rela-
tive to those in ESCs. First, reprogramming involves expression
of known oncogenes such as c-Myc and Klf4, and is enhanced
by downregulating genes that promote genome stability such
as p53 (reviewed in Deng and Xu, 2009). Second, reprogram-
ming involves global epigenetic remodeling, including histone366 Cell Stem Cell 9, 366–373, October 7, 2011 ª2011 Elsevier Inc.alteration, genome-wide demethylation, and de novo DNAmeth-
ylation, which may be mutagenic or lead to activation of endog-
enous retroelements (Koche et al., 2011; Lister et al., 2011).
Third, ESCs employ less error-prone DNA repair mechanisms
than do somatic cells, and failure to reset these during reprog-
ramming could contribute mutations to iPSCs (Fan et al., 2011;
Momcilovic et al., 2011). Finally, iPSCs are derived from differen-
tiated cell types instead of early embryos, suggesting that
somatic mutations in donor cells may contribute genetic diver-
sity to these cell lines, which could be deleterious.
A mutational class of particular concern is genomic struc-
tural variation (SV). SVs include duplications, deletions, inser-
tions, inversions, translocations, and complex rearrangements.
Because SVs can affect gene copy number and/or structure
and arise at high rates in unstable genomic regions (Zhang
et al., 2009), they are most likely to have a functional impact on
iPSCs or their derivatives. Moreover, a highly mutagenic source
of SV is transposition of endogenous retroelements, such as
LINEs, which have recently been shown to cause unexpectedly
high levels of genome diversity in germ line cells (Akagi et al.,
2008; Beck et al., 2010; Iskow et al., 2010; Quinlan et al., 2010;
Xing et al., 2009), tumors (Iskow et al., 2010), and some somatic
lineages (Coufal et al., 2009; Garcia-Perez et al., 2007; Muotri
et al., 2005). Whether retroelements become active during or
after reprogramming is not known.
Recent genome-wide surveys have reported that human
iPSC lines harbor high levels of de novo SV. One study (Mayshar
et al., 2010) used RNA expression analysis to indirectly assess
aneuploidy and large copy number variants (CNVs) at low
resolution (10 mb), and additional studies (Hussein et al.,
2011; Laurent et al., 2011; Martins-Taylor et al., 2011) used
array-based methods to map smaller CNVs. All report a highly
significant excess of CNVs in iPSCs relative to ESCs and fibro-
blasts. However, these studies were blind to smaller (<10 kb)
variants that comprise the vast majority of CNVs (Mills et al.,
2011), and could not detect balanced rearrangements or trans-
poson insertions, both of which are common in mammalian
genomes (Zhang et al., 2009). In this context the high mutational
burden reported by these studies is alarming, and raises the
question of whether the reprogramming process is inherently
mutagenic.
Cell Stem Cell
Genome Sequencing of iPSCsThis study aims to determine whether reprogramming to
pluripotency involves inherently mutagenic steps independent
of the effects of somatic development, extensive passaging,
and incomplete reprogramming. Therefore, we sought to
measure levels of de novo SV in early-passage iPSCs derived
from low-passage mouse embryonic fibroblasts (MEFs), using
methods that distinguish between mutations inherited from
donor cells and those acquired during reprogramming. We
also controlled for incomplete reprogramming by profiling iPSC
lines that generate viable mice derived entirely from the iPSCs
(termed fully pluripotent iPSCs) (Boland et al., 2009).
We analyzed the genomes of three iPSC lines using whole-
genome paired-end DNA sequencing and highly sensitive SV
detection algorithms, yet we observed strikingly few mutations
(one or two per line) and found no evidence for retroelement acti-
vation. These results argue that it is possible to identify iPSCs
lacking deleterious genomic changes using current reprogram-
ming methods.
RESULTS
Mapping SV
The most common methods for identifying CNVs are array
comparative genomic hybridization (array-CGH) and SNP geno-
typing arrays, which have limited resolution and cannot detect
balanced rearrangements or transposon insertions. To over-
come these limitations we examined iPSC genomes using Illu-
mina DNA sequencing and improved SV detection algorithms
(Figure 1A). We obtained 170–210 million paired-end sequence
reads (readpairs) from three iPSC lines and their parent fibro-
blasts, representing 103–123 physical coverage (Figure 1E),
and used two complementary approaches to identify SVs:
paired-end mapping (PEM) and read depth of coverage analysis
(DOC) (Figures 1B and 1C).
PEM involves clustering readpairs that span SV breakpoints
and can, in principle, identify all forms of SV. We used an
improved version of HYDRA, an algorithm we developed
previously (Quinlan et al., 2010). Importantly, HYDRA incorpo-
rates alternate mappings for readpairs derived from repetitive
elements (Figure 1B), which allows for identification of break-
points involving transposons and segmental duplications,
which are among the most mutable genomic elements. Our
iPSC lines were derived from a mixed strain mouse, and are
thus expected to differ from the C57BL/6J reference genome
by thousands of inherited SVs (Quinlan et al., 2010). Distin-
guishing de novo SV from inherited SV in this context is a
difficult and unsolved technical problem. We therefore devel-
oped a method to identify breakpoints from pooled multi-
sample data (Figure 1D; http://code.google.com/p/hydra-sv/)
that greatly increases the accuracy of determining whether a
given SV is a true de novo variant. Here we achieved 300 bp
resolution, which is at least 30-fold greater than the highest-
resolution iPSC genome surveys to date (Hussein et al., 2011;
Laurent et al., 2011).
DOC analysis relies on the observation that the local read
depth is directly related to DNA copy number, and is conceptu-
ally similar to array-CGH, yet more sensitive.We performed DOC
analysis with a custom algorithm (Quinlan et al., 2010) that
provides 15 kb resolution (Figure 1C).CiPSC Derivation and Lineage Analysis
To assess the inherent mutagenicity of reprogramming, we
wished to examine fully reprogrammed iPSCs that had not
been subjected to extensive passaging or clonal selection.
Here, we sequenced DNA from low-passage iPSC lines that
generate viable mice in tetraploid embryo complementation
(TEC) assays, demonstrating that they have completed reprog-
ramming (Boland et al., 2009). We produced these lines by
transducing MEFs with lentiviruses containing Oct4, Klf4,
Sox2, and c-Myc under the control of a doxycycline (dox)-induc-
ible promoter. Following viral transduction, the MEFs were
allowed to divide one or two times before reprogramming was
initiated by the addition of dox. This protocol allows us to identify
pairs of ‘‘sister’’ iPSC lines that arise from the same donor cell
(Figure 2A). Sister colonies arising at separate locations will
have identical patterns of proviral insertions but will have under-
gone distinct reprogramming events. Mutations common to both
sister lines, yet absent from other iPSCs, are likely to be SVs in-
herited from a donor cell, whereas mutations unique to a single
sister line must have arisen during or after reprogramming. In
this study we sequenced a pair of sister iPSCs (iMZ-9 and 21)
and a line that arose from a different donor cell (iMZ-11) (Boland
et al., 2009).
To confirm the lineage of sister iPSC lines and establish the
sensitivity of HYDRA, we mapped proviral insertion sites. We
aligned readpairs to both the reference genome and the lentiviral
gene sequences and identified HYDRA breakpoint calls consis-
tent with proviral integration events. This confirmed the clonal
origin of the iPSCs and accurately identified 21 proviral insertions
(Figure 2B), which is 3 more than could be clearly distinguished
in Southern blots (Boland et al., 2009). We also detected the
intronless reprogramming genes in the lentiviral vectors, as
expected (Figure 2C). These data provide an initial estimate of
the validity and sensitivity of our methods.
The Extent and Origin of SV in iPSCs
We applied DOC and PEM analyses to identify candidate de
novo SVs that are present in one or more iPSC lines but not in
the parental MEFs. Surprisingly, DOC analysis identified only
one de novo CNV (SV3), an 358 kb duplication in Plxna4 that
was also detected by PEM and was present only in iMZ-21 (Fig-
ure 1C, Figures 3A and 3B).
More sensitive PEM analyses using the HYDRA algorithm
identified 16,579 high-confidence SV breakpoints. Of these,
13,099 (79%) were detected in the parental MEF sample
and are thus, by definition, inherited variants. The remaining
3,480 breakpoints are candidate de novo mutations. This
number of candidates is expected to occur by chance given
the abundance of SV between mouse strains (Quinlan et al.,
2010) and the moderate physical coverage of our data sets.
While HYDRA achieves presence/absence breakpoint ‘‘geno-
typing’’ at 89%–94% accuracy in the four cell lines, the large
number of inherited SVs produces false mutation calls at
breakpoints that, by chance, lack sequence coverage in one
or more samples. We addressed this by using multinomial
sampling to prioritize candidate mutations whose readpair distri-
bution among the iPSC lines was unlikely to occur by chance.
We used PCR to validate 182 candidates (Figure S1, Table S1,
available online). Of these, 101 were present in all samples andell Stem Cell 9, 366–373, October 7, 2011 ª2011 Elsevier Inc. 367
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Figure 1. Structural Variant Detection
(A) Schematic of Illumina paired-end DNA sequencing.
(B) Breakpoint detection by PEM. Most readpairs are concordant (green) and map to the reference genome with the expected size and orientation (arrows), but
readpairs that span SV breakpoints map in ‘‘discordant’’ fashion (red). Each breakpoint class yields a distinctive pattern.
(C) CNV detection by read depth of coverage analysis (DOC). DOC uses local read depth to measure DNA copy number in a manner that is analogous to array-
CGH. Shown is 12.5 mb region that harbors the lone de novo CNV identified by DOC. Each data point is a 5 kb window, shown in genome order (x axis), and DNA
copy number is expressed as the Z-score (y axis) of the indicated iPSC line relative to the donorMEF sample. Note that iMZ-21 clearly shows a 358 kb duplication
(SV3) relative to the MEF sample.
(D) A multisample PEMmethod using pooled data. A hypothetical region from an experimental genome (Exp.) is shown above the reference genome (Ref.). In this
schematic segment C is deleted, E and F are inverted, and J is deleted. HYDRA screens for clusters of discordant readpairs (colored) that support the same
breakpoint. Germline SVs will be present in all four lines. De novo SVs will be present in a subset of iPSC lines. With our method, the four samples are combined
into a single HYDRA analysis and breakpoint ‘‘genotypes’’ are inferred from the number of readpairs contributed by each. The origin of each readpair is indicated
by its color, which corresponds to the colors of the labeled samples below. Shown are cartoon representations of SV1 and SV2a, as well as a hypothetical
germline variant.
(E) The total number of readpairs and genome coverage collected for each strain (top) and a plot showing the fraction of the genome in each line having greater
than or equal to various levels of physical coverage.
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Genome Sequencing of iPSCsthus represent germline variants; 18 candidates failed two inde-
pendent PCR attempts, either because they were false positive
calls or due to primer failure; and 64 breakpoints were validated
as de novomutations (Table S3). These represent 45 distinct SVs
(Table S2).
SVs include multiple mutational classes. Of the 45 de novo
SVswe identified, only four fell into the ‘‘canonical’’ class defined
as deletions, duplications, and inversions (Figures 3A–3C). The
remaining 41 were insertions of an exogenous retroelement,368 Cell Stem Cell 9, 366–373, October 7, 2011 ª2011 Elsevier Inc.which we discuss later. The sister lines (iMZ-9 and 21) shared
one mutation (SV2) not found in iMZ-11 or the MEFs, suggesting
that SV2 originated as a somatic mutation in the donor MEF.
SV2 is a complex rearrangement on chromosome 11 marked
by two large (31.3 kb and 43.7 kb) overlapping inversion break-
point calls (Figure 3B). The simplest explanation for this break-
point pattern is an 12 kb inverted duplication in which the
duplicated segments are separated by 31 kb of nondupli-
cated sequence. DOC analysis supports this interpretation.
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Figure 2. iPSC Lineages
(A) iPSC lineages. MEFs were transduced with five lentiviruses encoding the
four reprogramming factors and a drug-inducible transcriptional activator
(rTTAM2.2). After viral transduction MEFs were split and allowed to divide one
time before we induced reprogramming. This scheme produces clonally
transduced fibroblasts that undergo different reprogramming events and
produce distinct iPSC lines.
(B) The patterns of proviral integration events identified by HYDRA demon-
strate that iMZ-9 and iMZ-21 have identical proviral insertions whereas iMZ-11
is distinct. Thus, iMZ-9 and iMZ-21 are derived from the same original
fibroblast cell. Genomic differences between these lines represent post-
transduction changes, whereas shared SVs likely represent somatic mutations
present in the donor cell.
(C) Positive control ‘‘variant’’ calls resulting from the structure of the lentiviral
vectors. The vectors contain the four reprogramming genes. The junctions
between vector and transgene sequences manifest as four SVs. In addition,
three of the four transgenes lack introns relative to their copies in the reference
genome, which produces three control variants.
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Genome Sequencing of iPSCsThe duplicated segment lies between two alternatively spliced
first exons of Kcnj12, an inwardly rectifying potassium channel
expressed in the brain, the heart, and other tissues (Oyamada
et al., 2005). Each line also contained one additional line-specific
SV. The iMZ-21 line carried SV3, a 358 kb multiexon duplication
in Plxna4 which is a cell surface signaling protein expressed
in multiple tissues including the brain, blood, and heart (Suto
et al., 2003). Line iMZ-9 carried SV1, an 3.5 kb deletion that
removes three exons of Cspp1, a widely expressed gene
involved in cytokinesis and cell cycle (Asiedu et al., 2009).
Strikingly, line iMZ-11 carried only a single 400 bp deletion in
a nongenic region (SV4).
To infer the origin of each putative de novo SV, we generated
95 subclones of each iPSC line and performed PCR (Figure 3D).CThis showed that SV2, as expected, is present in all subclones,
whereas SV1 and SV3 are mosaic (65% and 97%, respectively),
consistent with their arising early in reprogramming or providing
a selective advantage to the iPSCs. SV4 was present in all
subclones, consistent with a somatic donor origin. However,
SV4 is located only 524 bp from a proviral integration site, sug-
gesting an alternative scenario in which it arose concomitantly
with viral insertion (Figure 3B). The mechanism for such an event
is unclear, but we note that adjacent deletions are associated
with a subset of SINE retroelement insertions in the human
genome (Xing et al., 2009).
To gain insight into the mechanisms responsible for these
rearrangements, we sequenced each SV breakpoint (Figure S2).
None exhibit more than 5 bp of homology and SV3 contains
a 12 bp insertion. This indicates that the SVs did not arise
through nonallelic homologous recombination (NAHR) but
instead through nonhomologous end-joining (NHEJ) or microho-
mology-mediated break-induced replication (MMBIR) (Hastings
et al., 2009). The complex multibreakpoint structure of SV2 and
the insertion in SV3 are more characteristic of MMBIR.
SVs Contribute to Tissues of Chimeric and iPSC Mice
To address the functional relevance of these variants, we
analyzed tissues from iPSC mice and from chimeric mice with
iPSC contribution. Previous studies indicate that mice generated
by these methods derive from at most three pluripotent cells
(Wang and Jaenisch, 2004). Thus, selection against SV1 in the
early embryo (65% of iMZ-9 cells) could result in its absence
from tissues of iPSC mice, while selection against SV2 (100%
of iMZ-9 cells) could exclude this SV from tissues in chimeric
mice. However, genomic PCR showed that SVs could be de-
tected in tissues of chimeric or iPSC mice (Figure 3E, iMZ-11
data not shown). In addition, RT-qPCR analyses of the genes
affected by SV1, SV2, and SV3 indicate that their expression is
reduced in iPSCs and/or relevant tissues (Figure S2).
Retroelement Silencing Is Maintained in iPSCs
The mouse genome contains numerous endogenous retroele-
ments that are repressed in somatic cells but active in germ cells,
early embryonic lineages, and cells with epigenetic perturbations
(Maksakova et al., 2008). The epigenetic remodeling that occurs
during reprogramming could activate these normally repressed
retroelements, whichwould be highly deleterious. HYDRA allows
us to address this important unanswered question at the whole-
genome level.
We identified 41 retroelement insertion events among the
three iPSC lines. Strikingly, all 41 were endogenous retrovirus
elements from the mouse leukemia virus (MLV) family. Each
iPSC line displayed a distinct insertional pattern, indicating that
transposition occurred during or after reprogramming (Fig-
ure 4A). However, closer inspection of the MLV sequence
showed that it was not an endogenous element because it con-
tained 58 single nucleotide polymorphisms (SNPs) that were not
present in the most similar MLV sequence in the donor MEFs
(Figure S4). SNP genotyping confirmed that the mutagenic
MLV element matched an MLV found in CF-1 MEFs that were
used as feeder cells, suggesting that these feeders transmitted
an activated MLV to the iPSCs (Figure 4B). This effect seems
to be batch specific because other similarly derived fullyell Stem Cell 9, 366–373, October 7, 2011 ª2011 Elsevier Inc. 369
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Figure 3. SVs Arise prior to and during Reprogramming and Contribute to Tissues
(A) The number of supporting readpairs per breakpoint call is indicated by the numbers in the boxes. The table at left describes the type, size, and location of each
SV and associated breakpoint.
(B) Schematic diagrams of SV1–4. Three of four SVs interrupt genic regions. Black lines denote nonexonic DNA and black or gray boxes represent exons or the
proviral insertion near SV4. Transcription start sites are denoted by arrows above exons. Breakpoints are denoted by inverted black triangles for SV1, 3, and 4 and
by the black arrows flanking the inverted duplication in SV2. The schematics are not to scale, but the size of each region is shown. Dashed lines indicate the
change between the wild-type and mutated chromosome.
(C) PCR confirmation of the four SVs identified in this study. Primers were designed to amplify breakpoint-spanning PCR products that produce a unique band
in the line (or lines) harboring the SV.
(D) The percentage of 95 iPSC subclones for each line that is positive for a given SV by PCR assays.
(E) Tissues from iPSC mice (iPSm 9-1, 9-2, and 21-1) and a chimeric mouse with iMZ-9 contribution were examined for the presence of SV1-2 (upper panel) and
SV3 (lower panel). All SVs are present in all tested tissues, but not the parental MEFs (MEF) or those harvested at the same time from a sibling embryo (MEF3). PCR
for the Cre recombinase gene (CRE) present in the iMZ iPSCs serves as a control for iPSC contribution.
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Genome Sequencing of iPSCspluripotent iPSC lines that were expanded on a different batch of
CF-1 feeders lack insertions (Figure 4C and K.K.B., unpublished
data). This underscores the precautions that must be takenwhen
working with feeder cells.
Importantly, we did not detect a single de novo endogenous
retroelement transposition among the iPSC lines, despite the
demonstrated sensitivity of our detection methods. This sug-
gests that reprogramming using the canonical ‘‘Yamanaka’’
factors (Oct4, Sox2, Klf4, and c-Myc) can preserve retroelement
silencing throughout the dramatic epigenetic changes required
to produce fully pluripotent iPSC lines.
Estimating the False Negative Rate
Given the paucity of new mutations discovered in this study,
a key question is how many we may have missed. To address
this we used two independent methods to estimate the false370 Cell Stem Cell 9, 366–373, October 7, 2011 ª2011 Elsevier Inc.negative rate (FNR) for SV detection. First, we evaluated
HYDRA’s ability to detect the lentiviral insertions used for reprog-
ramming. Using a combination of Southern blots (Boland et al.,
2009), PEM, manual inspection of raw sequence data, and
PCR validation, we identified 24 proviral insertions representing
48 breakpoints. This is three more insertions than were detected
by HYDRA (Figure 2) and six more than detected by Southern
blots. We then measured the fraction of breakpoints that were
detected by HYDRA at sufficient confidence to be selected as
candidate mutations for experimental validation. This resulted
in a per variant FNR of 4%–47%, depending on the iPSC line
and SV class (i.e., one or two breakpoint SVs). Second, we
assessed detection of 2,284 inherited SVs caused by segre-
gating variation among mouse strains (Quinlan et al., 2010).
This predicted a per variant FNR of 22%–53%. Therefore, in
the worst case we have missed roughly half of the SVs that exist
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Figure 4. Analysis of Repetitive Element Insertions
(A) No endogenous transposon insertions were detected; however, multiple MLV insertions were apparent in each iPSC line. The 41 MLV insertions are shown in
a heatmap, following the conventions outlined in Figure 1. Because eachMLV insertion is private to a given cell line, they occurred during or after reprogramming.
(B) A portion of the MLV element was amplified by PCR and individual clones were sequenced and analyzed for diagnostic SNPs. Nonreference genome (mm9)
alleles are found in the MLV consensus sequence, which was assembled from 41 MLV copies present in the iPSC lines, and in the CF-1 feeder cells (‘‘feeder’’),
which demonstrates that the additional iPSC MLV copies originate from the feeders.
(C) MLV Southern blot analysis of iPSCs and ESCs. A PCR fragment was used to probe DNA isolated from iMZ iPSCs and iPSCs derived by the same method on
different lots of feeders (iMZ2) as well as ESCs derived on CF-1 feeders. The CF-1 primary MEFs used to generate feeders contain multiple copies of the MLV
element as do the iMZ iPSCs, but the other iPSCs and ESCs possess only the chr8 band.
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Genome Sequencing of iPSCsin these genomes, which means that the iPSCs harbor two to
four total mutations. These calculations strongly support our
conclusion that very few de novo SVs exist in these iPSC lines.
One caveat is that PEM cannot detect breakpoints formed by
NAHR between large repeats, but this should be a minor source
of false negatives. NAHR mutations are detectable by DOC
analysis, and NAHR is less frequent in somatic cells than in the
germline (Hampton et al., 2009; Hillmer et al., 2011), where it
accounts for merely 10%–22% of inherited SV (Conrad et al.,
2010; Kidd et al., 2010; Mills et al., 2011). A second caveat is
that current genome-wide methods cannot detect SVs that are
present only in small subsets of cells, such as mutations that
arise late during cell expansion.
DISCUSSION
We have examined the mutational burden of a set of fully plurip-
otent mouse iPSCs using whole-genome DNA sequencing and
comprehensive SV detection algorithms. Despite the resolution
and scope of our methods, we observed only four SVs among
the three iPSC lines, and iMZ-11 had only a single mutation in
a nongenic region. Importantly, we did not observe a single
new retrotransposon insertion. Our results argue that current
reprogramming methods can produce fully pluripotent iPSC
lines that lack severe genomic alterations, even in the presence
of c-Myc.
Our results contrast with recent microarray-based studies
that have reported high levels of CNV in human iPSC lines
(Hussein et al., 2011; Laurent et al., 2011; Martins-Taylor et al.,C2011; Mayshar et al., 2010). One explanation for our results is
that the lines we analyzed are atypical. Two pieces of evidence
argue against this. First, our lines were not hand-selected for
pluripotency, but are instead the first three of seven lines gener-
ated using a specific protocol that efficiently produces fully
pluripotent iPSCs (6/6 lines tested; K.K.B., unpublished data).
Second, it is unlikely that we have selected mutation-poor lines
by chance alone. The highest resolution study to date examined
22 iPSC lines and discovered amean excess of 97 CNVs in iPSC
lines relative to ESC and fibroblast lines (Hussein et al., 2011).
If we randomly select three data sets from Hussein et al., the
probability of finding fewer than 42 CNVs is 0.05 (100,000
permutations) (Figure S3). Here, we found a total of four variants
in three iPSC lines, only one of which is detectable by microar-
rays. Moreover, the resolution of our analysis is 30-fold higher
than that of Hussein et al., and application of HYDRA to three
human data sets with similar levels of coverage to our iPSC
data sets reveals 46-fold more SV breakpoints than they re-
ported for control fibroblast lines (mean of 2,517 variants versus
55). These results suggest that the iPSC populations surveyed
in the two studies truly differ in their SV burden.
The reduced numbers of SVs in these mouse iPSCs could
reflect inherent differences between mouse and human iPSCs.
Alternatively, it could be related to unique aspects of our reprog-
ramming methods or be a consequence of more complete
reprogramming of the mouse iPSC lines. Additional experiments
are needed to resolve this important question.
A noteworthy aspect of our study is that it was designed to
establish the likely origin of each mutation. Encouragingly, weell Stem Cell 9, 366–373, October 7, 2011 ª2011 Elsevier Inc. 371
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ming per se, and one that was likely caused by lentiviral insertion.
This suggests that some iPSCs generated by ourmethodmay be
completely free of de novo SVs, at least prior to passaging or
expansion. However, we also identified a rearrangement (SV2)
that almost certainly arose in the donor somatic cell. This is
surprising given that donor cells were derived from embryonic
day 13.5 fibroblasts. In contrast, adult cells have likely under-
gone orders of magnitude more divisions as well as exposure
to mutagens and potential changes in genome stability that arise
during aging or differentiation. Thus, many more somatic SVs
may be apparent in iPSC lines derived from adult tissues. In
support of this, recent exome sequencing-based studies
revealed elevated numbers of point mutations in human iPSCs,
of which some were found in donor cells (Gore et al., 2011;
Howden et al., 2011). While our current data sets cannot deter-
mine whether our iPSC lines also harbor fewer point mutations
than human lines, we expect that future genome sequencing
efforts will resolve this question.
With the rapid adoption of iPSC and reprogramming technol-
ogies, the prospect of bringing patient-specific cell replacement
therapy to the clinic is becoming increasingly likely. Here we
establish a method to survey iPSC genomes for SVs that arise
either during somatic development or reprogramming, and we
show that it is possible to achieve reprogramming to full pluripo-
tency with a very low level of mutation. These results underscore
the importance of using whole-genome sequencing to compare
the relative mutagenicity of different reprogramming protocols in
order to accelerate the production of mutation-free iPSCs for
clinical and research applications.
EXPERIMENTAL PROCEDURES
DNA Sequencing of iPSCs
We derived iPSC lines and chimeric and iPSC-derived mice as described
(Boland et al., 2009). We removed iPSC colonies from MEF feeders, isolated
DNA, and constructed paired-end sequencing libraries according to standard
protocols (Bentley et al., 2008). We prepared two to five libraries per line and
sequenced with an Illumina GA2. Read lengths were 42 bp and the median
fragment length was 330 bp. Readpairs were first aligned with BWA
(Li and Durbin, 2009), and subsequently realigned with NOVOALIGN to identify
concordant readpairs missed by BWA and to report up to 1,100 alignments per
readpair.
SV Discovery
SV breakpoints were identified using HYDRA (Quinlan et al., 2010). We
combined discordant mappings from the four lines into a single input file,
and after breakpoint mapping we calculated the number of readpairs contrib-
uted by each sample using the hydraFrequency program in the HYDRA suite.
There were 67,797 breakpoint calls in the raw unfiltered output file, which
includes all breakpoints identified by two or more readpairs.
To obtain a final set of high-confidence HYDRA calls, we used BEDTOOLS
(Quinlan and Hall, 2010) to exclude calls whose aligned ends overlapped an
annotated simple sequence repeat (SSR) bymore than 50%. This is necessary
because SSRs are highly repetitive and often poorly assembled in the refer-
ence genome, causing numerous false positives (Quinlan et al., 2010). Second,
we required that the readpairs comprising each HYDRA call align to the refer-
ence genome with a mean edit distance <2 on both ends. This step increases
accuracy because false calls can result from low quality alignments that occur
when readpairs originating from repetitive or misassembled genomic regions
are aligned to incorrect genome positions. Third, we required that the mean
number of mappings for the readpairs contained in a HYDRA call were less
than 1,000 when one of the two ends was unique, and less than 100 when372 Cell Stem Cell 9, 366–373, October 7, 2011 ª2011 Elsevier Inc.both ends were repetitive. These filters reduced the 67,797 raw HYDRA break-
point calls to a final high-confidence set of 16,579.
To identify CNVs we analyzed read depth of coverage (corrected for GC-
content) in 5 kb windows using a previously described Hidden Markov Model
(HMM)-based method (Quinlan et al., 2010).
Identification of Candidate Mutations
Of the 16,579 breakpoint calls, 3,480 were not found in the MEF donor sample
and represent candidate de novo SVs. However, many of these are expected
to occur by chance due to mouse strain variation. We used a multinomial
sampling approach that accounts for the relative sequence coverage in
each strain to rank variants. We performed validation experiments on all 84
candidate mutations that had a probability of occurring by chance of less
than 0.001. We also selected an additional 98 candidates with a probability
less than 0.01. These 98 include all breakpoints that (1) involved the MLV
element; (2) were identified in both the iMZ-9 and iMZ-21 lines, but not
iMZ-11 and MEF; (3) were identified in a single iPSC line; or (4) were identified
by DOC analysis.
FNR Calculations
To intersect HYDRA calls with ‘‘true’’ breakpoints, we used pairToPair in the
BEDTOOLs suite, requiring strand-specific overlap between both ends. To
acquire the set of 48 ‘‘true’’ proviral integration breakpoints, we used results
from HYDRA and Southern blots, and we inspected raw sequence data to
identify single readpairs that mapped to the reference genome on one end
and the lentiviral vector sequence on the other. Since the latter can be caused
by artifacts (e.g., chimeras), we performed PCR to ensure their validity (3/7 vali-
dated). To acquire the set of 2,284 ‘‘true’’ inherited germline breakpoints, we
intersected the 67,797 unfiltered HYDRA calls from this study with 7,784
breakpoints previously identified in the DBA/2J strain (Quinlan et al., 2010).
For calculations of FNR we assessed the fraction of breakpoints in each set
that were identified by HYDRA at sufficient confidence to be put forward for
experimental validation, using precisely the same filtering and prioritization
approach used to identify candidate mutations. To assess the FNR of pres-
ence/absence breakpoint genotyping in each iPSC line, we calculated the
fraction of 1,854 high confidence germline breakpoints that were not detected
by one or more readpairs.
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